Bayer Aktiengesellschaft (BAYRY)
| Previous Close | 7.36 |
| Open | 7.29 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 7.27 - 7.39 |
| 52 Week Range | 6.96 - 16.81 |
| Volume | |
| Avg. Volume | 2,056,041 |
| Market Cap | 28.962B |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.80 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.03 (0.40%) |
| Ex-Dividend Date | Apr 29, 2024 |
| 1y Target Est | 28.89 |
- Reuters
Bayer confirms 2024 outlook despite slow start for agriculture, consumer health units
FRANKFURT (Reuters) -Bayer confirmed its full-year forecast for earnings and cash flow on Monday despite slow business at its crop science and consumer health divisions. "Our Crop Science and Consumer Health divisions expect a slow start to the year due to market dynamics, but we feel confident in our full-year targets and the direction of our businesses," CEO Bill Anderson said in his speech for the April 26 annual general meeting (AGM), which was posted on the company's website on Monday. The CEO reiterated that 2024 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items and currency swings, would decline between 3% and 9% and that free cash flow would reach 2-3 billion euros ($2.1-$3.2 billion) up from 1.3 billion last year.
FortunePharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
Chief executive Bill Anderson says he doesn’t want it to be a "lame" company, but its stock has still tanked 50%.
Insider MonkeyHere’s Why Bayer Aktiengesellschaft (BAYRY) Detracted in Q1
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]
